Cargando…

Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula

The authors reviewed the published evidence on the presence of oligosaccharides in human milk (HMO) and their benefits in in vitro and in vivo studies. The still limited data of trials evaluating the effect of mainly 2′-fucosyllactose (2′-FL) on the addition of some of HMOs to infant formula were al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vandenplas, Yvan, Berger, Bernard, Carnielli, Virgilio Paolo, Ksiazyk, Janusz, Lagström, Hanna, Sanchez Luna, Manuel, Migacheva, Natalia, Mosselmans, Jean-Marc, Picaud, Jean-Charles, Possner, Mike, Singhal, Atul, Wabitsch, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164445/ https://www.ncbi.nlm.nih.gov/pubmed/30149573 http://dx.doi.org/10.3390/nu10091161

Ejemplares similares

Safety of the extension of use of 2’‐fucosyllactose (2’‐FL) and lacto‐N‐neotetraose (LNnT) as novel foods in food supplements for infants pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2022)

The in vivo effect of Lacto-N-neotetraose (LNnT) on the expression of type 2 immune response involved genes in the wound healing process
por: Farhadihosseinabadi, Behrouz, et al.
Publicado: (2020)

Safety of lacto‐N‐neotetraose (LNnT) produced by derivative strains of E. coli BL21 as a novel food pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2020)

The Role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition
por: Hegar, Badriul, et al.
Publicado: (2019)

Determination of 2′-Fucosyllactose and Lacto-N-neotetraose in Infant Formula
por: Austin, Sean, et al.
Publicado: (2018)

Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota
por: Elison, Emma, et al.
Publicado: (2016)

2′FL and LNnT Exert Antipathogenic Effects against C. difficile ATCC 9689 In Vitro, Coinciding with Increased Levels of Bifidobacteriaceae and/or Secondary Bile Acids
por: Vigsnaes, Louise Kristine, et al.
Publicado: (2021)

Partial Hydrolyzed Protein as a Protein Source for Infant Feeding: Do or Don’t?
por: Vandenplas, Yvan, et al.
Publicado: (2022)

Inefficient Metabolism of the Human Milk Oligosaccharides Lacto-N-tetraose and Lacto-N-neotetraose Shifts Bifidobacterium longum subsp. infantis Physiology
por: Özcan, Ezgi, et al.
Publicado: (2018)

Infant-gut associated Bifidobacterium dentium strains utilize the galactose moiety and release lacto-N-triose from the human milk oligosaccharides lacto-N-tetraose and lacto-N-neotetraose
por: Moya-Gonzálvez, Eva M., et al.
Publicado: (2021)

Modular pathway engineering of key precursor supply pathways for lacto-N-neotetraose production in Bacillus subtilis
por: Dong, Xiaomin, et al.
Publicado: (2019)

Safety of lacto‐N‐fucopentaose I/2’‐fucosyllactose (LNFP‐I/2’‐FL) mixture as a novel food pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2023)

The Human Milk Oligosaccharides 3‐FL, Lacto‐N‐Neotetraose, and LDFT Attenuate Tumor Necrosis Factor‐α Induced Inflammation in Fetal Intestinal Epithelial Cells In Vitro through Shedding or Interacting with Tumor Necrosis Factor Receptor 1
por: Cheng, Lianghui, et al.
Publicado: (2021)

On the Term k lnn! in the Entropy
por: Stern, Otto
Publicado: (1949)

Growth, Tolerance, and Compliance of Infants Fed an Extensively Hydrolyzed Infant Formula with Added 2′-FL Fucosyllactose (2′-FL) Human Milk Oligosaccharide
por: Ramirez-Farias, Carlett, et al.
Publicado: (2021)

Safety of the extension of use of 2’‐fucosyllactose/difucosyllactose (2’‐FL/DFL) mixture and lacto‐N‐tetraose (LNT) as novel foods in food supplements for infants pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2022)

Safety of 3‐FL (3‐Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2021)

Heuristic Reordering Strategy for Quantum Circuit Mapping on LNN Architectures
por: He, Jinfeng, et al.
Publicado: (2022)

Retracted: Heuristic Reordering Strategy for Quantum Circuit Mapping on LNN Architectures
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Safety of the extension of use of 2′‐fucosyllactose (2′‐FL) as a novel food pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2023)

An Observational Real-Life Study with a New Infant Formula in Infants with Functional Gastro-Intestinal Disorders
por: Vandenplas, Yvan, et al.
Publicado: (2021)

Lacto-Peptine
por: Alexander, Laurence
Publicado: (1874)

Safety and efficacy of a probiotic-containing infant formula supplemented with 2’-fucosyllactose: a double-blind randomized controlled trial
por: Alliet, Philippe, et al.
Publicado: (2022)

Lacto-Bacillus Acidophilus
Publicado: (1926)

Lacto-Phosphate of Lime
Publicado: (1874)

Lacto-Bacillin in Pernicious Anæmia
Publicado: (1909)

Syrup of the Lacto-Phosphate of Lime
Publicado: (1872)

Quantifying the human milk oligosaccharides 2’‐fucosyllactose and 3‐fucosyllactose in different food applications by high‐performance liquid chromatography with refractive index detection
por: Christensen, Anne Støvlbæk, et al.
Publicado: (2020)

Influence of 2′-fucosyllactose and galacto-oligosaccharides on the growth and adhesion of Streptococcus mutans
por: Salli, K., et al.
Publicado: (2020)

Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal
por: James, Kieran, et al.
Publicado: (2019)

Bifidobacterium breve UCC2003 metabolises the human milk oligosaccharides lacto-N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct pathways
por: James, Kieran, et al.
Publicado: (2016)

Chemoenzymatic Synthesis of Asymmetrically Branched Human Milk Oligosaccharide Lacto-N-Hexaose
por: Ooi, Kai-Eng, et al.
Publicado: (2022)

Multi‐level metabolic engineering of Escherichia coli for high‐titer biosynthesis of 2′‐fucosyllactose and 3‐fucosyllactose
por: Li, Mengli, et al.
Publicado: (2022)

Transglycosylation Activity of Engineered Bifidobacterium Lacto-N-Biosidase Mutants at Donor Subsites for Lacto-N-Tetraose Synthesis
por: Castejón-Vilatersana, Mireia, et al.
Publicado: (2021)

Synthesis of the Tolerance-Inducing Oligosaccharide Lacto-N-Fucopentaose III Bearing an Activated Linker
por: Zhang, Junfeng, et al.
Publicado: (2013)

Production of a human milk oligosaccharide 2′-fucosyllactose by metabolically engineered Saccharomyces cerevisiae
por: Yu, Sora, et al.
Publicado: (2018)

Author Correction: Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal
por: James, Kieran, et al.
Publicado: (2020)

Human Milk Oligosaccharide 2′-Fucosyllactose Induces Neuroprotection from Intracerebral Hemorrhage Stroke
por: Hung, Tsai-Wei, et al.
Publicado: (2021)

Treatment of Exposed Pulps by Lacto Phosphate of Lime
por: Cravens, Junius E.
Publicado: (1876)

Novel lacto-peptides improve cognitive decline
por: Ano, Yasuhisa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_23jsu6p7be52buuggmcf2eg6n0